Bank of America upped its price target for Vertex Pharmaceuticals from $555 to $567, signaling growing confidence in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback